×

Dosage form for treating cardiovascular diseases

  • US 4,950,486 A
  • Filed: 11/07/1988
  • Issued: 08/21/1990
  • Est. Priority Date: 10/02/1987
  • Status: Expired due to Term
First Claim
Patent Images

1. A composition for use in an osmotic device, said composition comprising about 2 weight percent to 30 weight percent of isradipine, a polyethylene oxide comprising a molecular weight of about 200,000 to about 300,000 and a hydroxypropylemthylecellulose comprising a number average molecular weight of about 9,000 to 15,000.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×